
Clement B. Graham
Examiner (ID: 15395)
| Most Active Art Unit | 3691 |
| Art Unit(s) | 3696, 3691, 3628, 3692 |
| Total Applications | 381 |
| Issued Applications | 145 |
| Pending Applications | 51 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18965259
[patent_doc_number] => 11899016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Methods of identifying immune cells in PD-L1 positive tumor tissue
[patent_app_type] => utility
[patent_app_number] => 15/985638
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 21168
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985638 | Methods of identifying immune cells in PD-L1 positive tumor tissue | May 20, 2018 | Issued |
Array
(
[id] => 14233415
[patent_doc_number] => 20190128880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => METHOD FOR DETECTING THE TARGET IN A SAMPLE
[patent_app_type] => utility
[patent_app_number] => 15/965196
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965196
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/965196 | METHOD FOR DETECTING THE TARGET IN A SAMPLE | Apr 26, 2018 | Abandoned |
Array
(
[id] => 18545342
[patent_doc_number] => 11718682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Assays for TIMP2 having improved performance in biological samples
[patent_app_type] => utility
[patent_app_number] => 16/603071
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23471
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603071 | Assays for TIMP2 having improved performance in biological samples | Apr 3, 2018 | Issued |
Array
(
[id] => 14932979
[patent_doc_number] => 20190302127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHOD FOR DIAGNOSING TRAUMATIC BRAIN INJURY
[patent_app_type] => utility
[patent_app_number] => 15/941698
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/941698 | METHOD FOR DIAGNOSING TRAUMATIC BRAIN INJURY | Mar 29, 2018 | Abandoned |
Array
(
[id] => 16178279
[patent_doc_number] => 20200225247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS AND KITS FOR PREDICTING THE TRANSPLANTATION-FREE SURVIVAL TIME OF PATIENTS SUFFERING FROM CIRRHOSIS
[patent_app_type] => utility
[patent_app_number] => 16/495278
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495278 | METHODS AND KITS FOR PREDICTING THE TRANSPLANTATION-FREE SURVIVAL TIME OF PATIENTS SUFFERING FROM CIRRHOSIS | Mar 19, 2018 | Abandoned |
Array
(
[id] => 13495785
[patent_doc_number] => 20180299435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 15/914449
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914449 | IMMUNOASSAY | Mar 6, 2018 | Abandoned |
Array
(
[id] => 17891672
[patent_doc_number] => 11454634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Assessing whether a subject shall be subjected to imaging based diagnostic
[patent_app_type] => utility
[patent_app_number] => 15/911699
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 32415
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15911699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/911699 | Assessing whether a subject shall be subjected to imaging based diagnostic | Mar 4, 2018 | Issued |
Array
(
[id] => 14932945
[patent_doc_number] => 20190302110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Quick validation method for binding kinetic analysis
[patent_app_type] => utility
[patent_app_number] => 15/910840
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910840 | Quick validation method for binding kinetic analysis | Mar 1, 2018 | Abandoned |
Array
(
[id] => 15347955
[patent_doc_number] => 20200011869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => NON-INVASIVE DIAGNOSIS OF FIBROTIC NON-ALCOHOLIC STEATOHEPATITIS
[patent_app_type] => utility
[patent_app_number] => 16/486884
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486884
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486884 | NON-INVASIVE DIAGNOSIS OF FIBROTIC NON-ALCOHOLIC STEATOHEPATITIS | Feb 26, 2018 | Abandoned |
Array
(
[id] => 15559865
[patent_doc_number] => 20200064344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => USE OF SERUM 2-CYSTEINE PEROXIREDOXINS (2-CYS-PRDX) AS BIOMARKERS OF CHRONIC KIDNEY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/483251
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483251 | USE OF SERUM 2-CYSTEINE PEROXIREDOXINS (2-CYS-PRDX) AS BIOMARKERS OF CHRONIC KIDNEY DISEASES | Feb 4, 2018 | Abandoned |
Array
(
[id] => 17282524
[patent_doc_number] => 11199549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
[patent_app_type] => utility
[patent_app_number] => 15/883126
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5006
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883126
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/883126 | MEl'hods and means for diagnosing spondylarthritis using autoantibody markers | Jan 29, 2018 | Issued |
Array
(
[id] => 12794968
[patent_doc_number] => 20180156825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => METHOD FOR ASSISTING DIAGNOSIS OF CONDITIONS OF MYELOFIBROSIS
[patent_app_type] => utility
[patent_app_number] => 15/878713
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878713
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878713 | METHOD FOR ASSISTING DIAGNOSIS OF CONDITIONS OF MYELOFIBROSIS | Jan 23, 2018 | Abandoned |
Array
(
[id] => 16666319
[patent_doc_number] => 10935557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Immunoassay for free vitamin D
[patent_app_type] => utility
[patent_app_number] => 15/862318
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4601
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15862318
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/862318 | Immunoassay for free vitamin D | Jan 3, 2018 | Issued |
Array
(
[id] => 14470981
[patent_doc_number] => 20190187133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => DIAGNOSTIC REAGENT KIT FOR DETECTING CHRONIC BRAIN PATHOLOGIES OF ISCHEMIC GENESIS
[patent_app_type] => utility
[patent_app_number] => 16/307491
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307491 | Diagnostic reagent kit for detecting chronic brain pathologies of ischemic genesis | Dec 19, 2017 | Issued |
Array
(
[id] => 12261744
[patent_doc_number] => 20180080941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL'
[patent_app_type] => utility
[patent_app_number] => 15/824942
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2931
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/824942 | EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL | Nov 27, 2017 | Abandoned |
Array
(
[id] => 12754120
[patent_doc_number] => 20180143207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 15/821578
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821578 | METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT | Nov 21, 2017 | Abandoned |
Array
(
[id] => 15180683
[patent_doc_number] => 20190360933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METAL-ORGANIC FRAMEWORKS AS PROTECTIVE COATINGS AND FOR ENHANCING SENSITIVITY OF BIODIAGNOSTIC CHIPS
[patent_app_type] => utility
[patent_app_number] => 16/461725
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461725 | METAL-ORGANIC FRAMEWORKS AS PROTECTIVE COATINGS AND FOR ENHANCING SENSITIVITY OF BIODIAGNOSTIC CHIPS | Nov 16, 2017 | Abandoned |
Array
(
[id] => 12644949
[patent_doc_number] => 20180106814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/809160
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809160 | METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE | Nov 9, 2017 | Abandoned |
Array
(
[id] => 17876641
[patent_doc_number] => 11448648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease
[patent_app_type] => utility
[patent_app_number] => 16/349233
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 10342
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349233 | Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease | Nov 9, 2017 | Issued |
Array
(
[id] => 17743685
[patent_doc_number] => 11391745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method of detecting arteriosclerosis
[patent_app_type] => utility
[patent_app_number] => 16/349842
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8896
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349842 | Method of detecting arteriosclerosis | Nov 9, 2017 | Issued |